Security key
92511W108
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 9,937,044
- Total 13F value
- $112,291,153
- Share change
- +10,656
- SEC-reported price per share
- $11.30
- Number of holders
- 53
- Value change
- -$1,689,115
- Number of buys
- 22
- Number of sells
- 26
- Shares outstanding
- 92,448,158
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
53
Top holders
10
VRCA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W108
Recent filing periods:
Ownership snapshot
Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 3.9%
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 3.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
3.9%
ORBIMED ADVISORS LLC
1.6%
KORNITZER CAPITAL MANAGEMENT INC /KS
0.78%
VANGUARD GROUP INC
0.77%
BlackRock Finance, Inc.
0.76%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
3.9%
|
$54,698,000
3,610,412 shares
|
— | 31 Mar 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.6%
|
$22,418,000
1,479,733 shares
|
— | 31 Mar 2021 |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
Company
|
0.78%
|
$10,906,000
719,836 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
0.77%
|
$10,766,000
710,683 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
0.76%
|
$10,624,000
701,230 shares
|
— | 31 Mar 2021 |
| Altium Capital Management LLC |
13F
Company
|
0.61%
|
$8,529,000
562,954 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
53
Shares
9,937,044
Rows available
53
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
51
Q2 2021 holders
53
Holder diff
2
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend